The Journal of Practical Medicine >

2023 , Vol. 39 >Issue 16: 2050 - 2056

DOI: https://doi.org/10.3969/j.issn.1006-5725.2023.16.007

Basic Research

Exploring the mechanism of using andrographolide to inhibit triple negative breast cancer based on Hippo/YAP signaling pathway

  • Cuixia HUANG ,
  • Yaqian ZHANG ,
  • Aiping YANG ,
  • Ruihanqiu LIU ,
  • Yan LU
Expand
  • Research Center for Integrative Medicine，college of Basic Medical Sciences，Guangzhou University of Chinese Medicine，Guangzhou 510006，China

Received date: 2023-04-07

  Online published: 2023-09-26

Fold

Abstract

Objective To explore the effect of andrographolide on proliferation， migration， stem cell properties and epithelial-mesenchymal transition process of triple negative breast cancer cells and its mechanism through in vivo and in vitro experiments. Methods Sulforhodamine B method was used to detect the Cell viability.Migration，the proportions of CD44+/CD24-/low and the proliferation level of cancer stem cells were detected by wound healing assay， flow cytometry andmanmospheres assay，respectively.Western blot was used to detect the effects of andrographolide on the expression levels of YAP， ANKRD1， NESTIN， NANOG， E-cadherin， Vimentin， N-cadherin， Fibrone-Ctin YAP，ANKRD1， NESTIN， NANOG， E-cadherin， Vimentin， N-cadherin，Fibronectin and p-YAPin MDA-MB-231 and 4T1 cells. The effect of andrographolide on proliferation of breast cancer cells in vivo and the tumorigenicity of mice were examined through tumor transplantation experiment in mice.The expressions of YAP and ANKRD1 of tumor in mice was detected by immunohistochemistry. Results In vitro experiment results showed that cell viability of MDA-MB-231 and 4T1 cellstreated with andrographolide was decreased.in a dose-dependent manner.Compared with the control group， the healing rate of cells， the proportions of CD44+/CD24-/low andthe volume and the number of stem cell microspheres in MDA-MB-231 and 4T1 cells were reduced（P < 0.05）.After andrographolide treatment，the expressions of YAP， ANKRD1， NESTIN， NANOG，Vimentin，N-cadherin and Fibronectin in MDA-MB-231 and 4T1 cells were down-regulated. Meanwhile， while the expression of E-cadherin andp-YAP were increased.In vivo experiment results showed that Compared with the control group， tumor volume and weight decreased and tumor inhibitory rate increased significantly after Andrographolide intervention （P < 0.01）. And the expression of YAP andANKRD1 of tumor in mice decreased. Conclusion Andrographolide may play a role against triple-negative breast cancer by regulating the Hippo/YAP pathway.

Key words： triple negative breast cancer; andrographolide; yes-associatedprotein; epithelial-mesenchymal transition

Cite this article

Cuixia HUANG , Yaqian ZHANG , Aiping YANG , Ruihanqiu LIU , Yan LU . Exploring the mechanism of using andrographolide to inhibit triple negative breast cancer based on Hippo/YAP signaling pathway[J]. The Journal of Practical Medicine, 2023 , 39(16) : 2050 -2056 . DOI: 10.3969/j.issn.1006-5725.2023.16.007

References

1 KATSURA C， OGUNMWONYI I， KANKAM H K， et al.Breast cancer：presentation， investigation and management ［J］.Br J Hosp Med （Lond），2022，83（2）：1-7.
2 艾勇彪，黄军，袁杰，等. 早期三阴性乳腺癌中雄激素受体表达与临床病理特征及预后的关系［J］. 实用医学杂志，2023，39（8）：975-979.
3 MOHAJAN S， JAISWAL P K， VATANMAKARIAN M，et al.Hippo pathway：Regulation，deregulation and potential therapeutic targets in cancer［J］. Cancer Lett，2021，507：112-123. 112-123.
4 YU B， SU J， SHI Q， et al.KMT5A-methylated SNIP1 promotes triple-Negative brea -st cancer metastasis by activating YAP signaling［J］.Nat Commun，2022，13（1）：2192.
5 THOMPSON B J.YAP/TAZ：Drivers of Tumor Growth，Metastasis， and Resistance to Therapy［J］.Bioessays，2020，42（5）：e1900162.
6 XU T， JIANG Y Y， YUAN S Y， et al.Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-ɑAxis［J］. Front Oncol，2022，12：899402.
7 WANG X R， JIANG Z B， XU C， et al.Andrographolide suppresses non-small-non Lung cancer progression through induction of autophagy and antitumor immune response［J］. Pharmacol Res， 2022，179：106198.
8 LIU Z Y， WU X P， DAI K， et al. The new andrographolide derivative AGS-30 induces apoptosis in human colon cancer cells by activating a ROS-dependent JNK signalling pathway［J］. Phytomedicine，2022，94：153824.
9 HE J， CHEN Z， XUE Q， et al.Block of Proliferation 1 Promotes Proliferation， Invasion and Epithelial Mesenchymal Transformation in Gastric Cancer［J］. Oxid Med Cell Longev，2022，2022：2946989.
10 鹿蓓蓓，傅鹤秀， OKRAH E A，等，穿心莲内酯对小鼠乳腺癌的抑制作用和机制 ［J］. 中国药理学通报，2022，38（1）：26-32.
11 Fu M， Hu Y， Lan T， et al.The Hippo signalling pathway and its implications in human health and diseases［J］. Signal Transduct Target Ther，2022， 7（1）：376.
12 MOHAJAN S， JAISWAL P K， VATANMAKARIAN M，et al.Hippo pathway：Regulation， deregulation and potential theraeutic targets in cancer［J］. Cancer Lett，2021，507：112-123.
13 MA S， MENG Z， CHEN R， et al.The Hippo Pathway： Biology and Pathophysiology ［J］. Annu Rev Biochem，2019，88：577-604.
14 CUNNINGHAM R， HANSEN C G. The Hippo pathway in cancer： YAP/TAZ and TEAD as therapeutic targets in cancer［J］.Clin Sci （Lond），2022，136（3）：197-222.
15 KUO C Y， CHANG Y C， CHIEN M N， et al. SREBP1 promotes invasive phenotyp- es by upregulating CYR61/CTGF via the Hippo-YAP pathway［J］. Endocr Relat cancer，2021，29（2）：47-58.
16 PAN X X， GENG Z， LI J Y， et al. Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling ［J］.Mol Cancer Ther，2022，21（7）：1160-1170.
17 MOYA I M， HALDER G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine［J］. Nat Rev Mol Cell Biol， 2019，20（4）：211-226.
18 SUN T， MAO W H， PENG H，et al.YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin［J］.Cell Oncol （Dordr），2021，44（3）： 689-699.
19 LUO J， ZOU H， GUO Y， et al. The oncogenic roles and clinical implications of YAP/TAZin breast cancer［J］. Br J Cancer，2023，128（9）：1611-1624.
20 YANG C E， LEE W Y， CHENG H W， et al.The antipsychotic chlorpromazine suppresses YAP signaling， stemness properties， and drug resistance in breast cancer cells［J］. Chem Biol Interact， 2019，302： 28-35.
21 徐钰，徐婷，熊远锋，等. 二甲双胍可能通过 Hippo-YAP通路抑制HER-2阳性乳腺癌细胞的增殖和促进凋亡［J］.南方医科大学学报，2022，42（5）：740-746.
22 LUO Y W， ZHOU J， TANG J N， et al. MINDY1 promotes bladder cancer progressi- on by stabilizing YAP［J］. Cancer Cell Int， 2021，21（1）：395.
23 TANG J N， LUO Y W， XIAO L. USP26 promotes anaplastic thyroid cancer progre- ssion by stabilizing TAZ［J］. Cell Death Dis， 2022，13（4）：326.
24 WANG L J， LI J， WANG R L，et al.NGF signaling interacts with the Hippo/YAP pathway to regulate cervical cancer progression［J］. Front Oncol，2021，11：688794.
25 朱德明，孔连宝，贾文博，等. ANKRD1通过介导上皮细胞间充质转化促进肝细胞肝癌增殖与转移［J］. 南京医科大学学报，2023，43（4）：484-491.
Options
Outlines

/

〈 〉